Clicky

Disc Medicine, Inc.(IRON) News

Date Title
Oct 11 Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week
Jun 14 Disc Medicine Announces Underwritten Offering of Common Stock
Jun 14 Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress
May 30 Disc Medicine to Participate in the Jefferies Global Healthcare Conference
May 14 Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress
May 13 Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference
May 11 Disc Medicine Inc (IRON) Reports Q1 2024 Earnings: A Detailed Financial Overview
May 9 Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update
Apr 4 Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
Apr 2 Disc Medicine (IRON) Down on Mixed Results From AURORA Study
Apr 1 Disc Medicine Plummets After Placebo Effect Confounds Sunlight Sensitivity Study
Apr 1 Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)
Mar 23 Disc Medicine Inc (IRON) Reports Earnings: A Detailed Look at Fiscal Performance
Mar 21 Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Mar 6 Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024
Dec 22 Peabody Energy, Janus International, and More Stocks See Action From Activist Investors
Dec 20 Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory Board
Dec 8 Insider Sell Alert: CFO Joanne Bryce Sells 2,541 Shares of Disc Medicine Inc (IRON)
Sep 6 With 52% ownership, Disc Medicine Opco Inc (NASDAQ:IRON) boasts of strong institutional backing
Aug 24 Stock Screen Finds These Growth Stocks Outperforming The S&P 500